John Fung to Case-Control Studies
This is a "connection" page, showing publications John Fung has written about Case-Control Studies.
Connection Strength
0.190
-
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl. 2005 Nov; 11(11):1425-30.
Score: 0.049
-
Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients. Surgery. 2016 10; 160(4):1097-1103.
Score: 0.026
-
Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation. Inflamm Bowel Dis. 2016 07; 22(7):1670-8.
Score: 0.026
-
Role of Doppler Sonography in Early Detection of Splenic Steal Syndrome. J Ultrasound Med. 2016 Jul; 35(7):1393-400.
Score: 0.025
-
Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi-blinded prospective randomized trial. Clin Transplant. 2015 Dec; 29(12):1173-80.
Score: 0.024
-
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant. 2003 Apr; 17(2):77-88.
Score: 0.010
-
Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc. 2001 Feb-Mar; 33(1-2):1134-5.
Score: 0.009
-
Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D. Liver Transpl. 2000 Jan; 6(1):92-6.
Score: 0.008
-
Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clin Pharmacol Ther. 1998 Mar; 63(3):296-302.
Score: 0.007
-
Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg. 1996 Jan; 223(1):70-6.
Score: 0.006